Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 21.591\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] COc1ccc(CNC(=O)CN(C(=O)CCC(=O)Nc2nccs2)c2cccc(C)c2)cc1
[b] COc1cccc(N=C2CC(C)(C)CC(=O)/C2=C(/O)c2ccccc2)c1
Answer: a. COc1ccc(CNC(=O)CN(C(=O)CCC(=O)Nc2nccs2)c2cccc(C)c2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CNC(=O)CN(C(=O)CCC(=O)Nc2nccs2)c2cccc(C)c2)cc1
COc1ccc(CNC(=O)CN(C(=O)CCC(=O)Nc2nccs2)c2cccc(C)c2)cc1
N'-[2-[(4-methoxyphenyl)methylamino]-2-oxoethyl]-N'-(3-methylphenyl)-N-(1,3-thiazol-2-yl)butanediamide